World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
33264
World Ranking
15418
National Ranking
7778

Overview

Michael J. Overman is affiliated with The University of Texas MD Anderson Cancer Center in the United States.

Their research is primarily situated within the field of Medicine, with a strong focus on Oncology. Specific subfields include Pathology and Forensic Medicine, Cancer Research, Pulmonary and Respiratory Medicine, and Surgery.

The scientist's work covers a range of topics related to cancer, particularly colorectal cancer. Key topics include:

  • Colorectal Cancer Treatments and Studies
  • Genetic factors in colorectal cancer
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Gastric Cancer Management and Outcomes
  • Pancreatic and Hepatic Oncology Research
  • Colorectal and Anal Carcinomas

Michael J. Overman has contributed to multiple recent papers, notably in clinical guidelines and cancer treatment research. Selected publications include:

  • Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology, 2021, Journal of the National Comprehensive Cancer Network
  • Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology, 2022, Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines Insights: Rectal Cancer, Version 6.2020, 2020, Journal of the National Comprehensive Cancer Network
  • Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142, 2022, Annals of Oncology
  • Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology, 2024, Journal of the National Comprehensive Cancer Network

Their frequent co-authors include Scott Kopetz, Kanwal Raghav, John Paul Shen, Robert A. Wolff, and Christine M. Parseghian.

Michael J. Overman has published extensively in a number of prominent scientific venues. These publication venues include:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • Cancer Research
  • Journal for ImmunoTherapy of Cancer
  • Clinical Cancer Research

Best Publications

  • Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study

    Michael J. Overman;Ray McDermott;Joseph L. Leach;Sara Lonardi

  • Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer

    Michael J. Overman;Sara Lonardi;Ka Yeung Mark Wong;Heinz Josef Lenz

  • Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy

    Scott Kopetz;George J. Chang;Michael J. Overman;Cathy Eng

  • Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

    Al B. Benson;Alan P. Venook;Mahmoud M. Al-Hawary;Mustafa A. Arain

  • Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases

    Dan G. Blazer;Yoji Kishi;Dipen M. Maru;Scott Kopetz

  • KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer

    Wenting Liao;Michael J. Overman;Adam T. Boutin;Xiaoying Shang

  • Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance.

    Scott Kopetz;Paulo M. Hoff;Jeffrey S. Morris;Robert A. Wolff

  • High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.

    K. Allenson;J. Castillo;F. A. San Lucas;G. Scelo

  • Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals from 2008 to 2018

    Jonathan M. Loree;Seerat Anand;Arvind Dasari;Joseph M. Unger

  • High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome

    Antoine Brouquet;Eddie K. Abdalla;Scott Kopetz;Christopher R. Garrett

  • Rectal cancer, version 6.2020: Featured updates to the NCCN guidelines

    Al B. Benson;Al B. Benson;Alan P. Venook;Alan P. Venook;Mahmoud M. Al-Hawary;Mahmoud M. Al-Hawary;Mustafa A. Arain;Mustafa A. Arain

  • Use of Research Biopsies in Clinical Trials: Are Risks and Benefits Adequately Discussed?

    Michael J. Overman;Janhavi Modak;Scott Kopetz;Ravi Murthy

  • Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?

    Antoine Brouquet;Melinda M. Mortenson;Jean Nicolas Vauthey;Miguel A. Rodriguez-Bigas

  • Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis

    Christopher Lieu;John Heymach;Michael Overman;Hai Tran

  • Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.

    Jorge Blando;Anu Sharma;Maria Gisela Higa;Hao Zhao

  • Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)

    J. Goldstein;B. Tran;B. Tran;J. Ensor;P. Gibbs;P. Gibbs

  • Phase II Study of Capecitabine and Oxaliplatin for Advanced Adenocarcinoma of the Small Bowel and Ampulla of Vater

    Michael J. Overman;Gauri R. Varadhachary;Scott Kopetz;Rosni Adinin

  • Classifying colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and consensus molecular subtypes

    Jonathan M Loree;Allan Al Pereira;Michael Lam;Alexandra N Willauer

  • Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma

    Sangeeta Goswami;Thomas Walle;Andrew E. Cornish;Andrew E. Cornish;Sreyashi Basu

  • First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study.

    Heinz-Josef Lenz;Eric Van Cutsem;Maria Luisa Limon;Ka Yeung Mark Wong

Frequent Co-Authors

Scott Kopetz
Scott Kopetz The University of Texas MD Anderson Cancer Center
Robert A. Wolff
Robert A. Wolff The University of Texas MD Anderson Cancer Center
Cathy Eng
Cathy Eng Vanderbilt University
Funda Meric-Bernstam
Funda Meric-Bernstam The University of Texas MD Anderson Cancer Center
James L. Abbruzzese
James L. Abbruzzese Duke University
Milind Javle
Milind Javle The University of Texas MD Anderson Cancer Center
Huamin Wang
Huamin Wang The University of Texas MD Anderson Cancer Center
Paul F. Mansfield
Paul F. Mansfield The University of Texas MD Anderson Cancer Center
Filip Janku
Filip Janku The University of Texas MD Anderson Cancer Center
David S. Hong
David S. Hong The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn't have to follow a single track. Numerous online degree options offer flexibility and accessibility to suit various ambitions and life circumstances.

For those seeking advanced clinical practice, the best online dnp programs provide a path to becoming a Doctor of Nursing Practice. This is ideal for nurses who want to lead in healthcare practice or administration.

Interested in pharmacy? Accredited pharmd online programs make it possible to study pharmaceutical science remotely and prepare for licensure as a pharmacist.

On the health information side, an him associate degree online can open doors to organizing and managing crucial medical data—an area in high demand as health informatics grows.

Additionally, if you’re considering a shorter, skills-focused track, exploring medical billing and coding cost can guide you toward a vital administrative role in healthcare without committing to a lengthy degree program.

Best Scientists Citing Michael J. Overman

Trending Scientists

Recently Published Articles